Search

Abdel A. Mohamed

Examiner (ID: 6501)

Most Active Art Unit
1654
Art Unit(s)
1653, 1806, 1811, 1654, 1815, 1611, 1803
Total Applications
1048
Issued Applications
680
Pending Applications
109
Abandoned Applications
258

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 655183 [patent_doc_number] => 07109299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-19 [patent_title] => 'Peptides and compounds that bind to the IL-5 receptor' [patent_app_type] => utility [patent_app_number] => 10/168372 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18803 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109299.pdf [firstpage_image] =>[orig_patent_app_number] => 10168372 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/168372
Peptides and compounds that bind to the IL-5 receptor Dec 15, 1999 Issued
Array ( [id] => 1534835 [patent_doc_number] => 06489290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Antiplatelet agent' [patent_app_type] => B2 [patent_app_number] => 09/381261 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12595 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489290.pdf [firstpage_image] =>[orig_patent_app_number] => 09381261 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/381261
Antiplatelet agent Dec 6, 1999 Issued
Array ( [id] => 1342404 [patent_doc_number] => 06586402 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'LH-RH peptide analogues, their uses and pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/450443 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14346 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586402.pdf [firstpage_image] =>[orig_patent_app_number] => 09450443 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/450443
LH-RH peptide analogues, their uses and pharmaceutical compositions containing them Nov 29, 1999 Issued
Array ( [id] => 1446798 [patent_doc_number] => 06369030 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Inhibitors of histone acetyltransferases (HATs) and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/451034 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 7787 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369030.pdf [firstpage_image] =>[orig_patent_app_number] => 09451034 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/451034
Inhibitors of histone acetyltransferases (HATs) and uses thereof Nov 28, 1999 Issued
Array ( [id] => 1534842 [patent_doc_number] => 06489292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Stable aqueous insulin preparations without phenol and cresol' [patent_app_type] => B1 [patent_app_number] => 09/441702 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489292.pdf [firstpage_image] =>[orig_patent_app_number] => 09441702 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/441702
Stable aqueous insulin preparations without phenol and cresol Nov 15, 1999 Issued
Array ( [id] => 1521719 [patent_doc_number] => 06414123 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Method for purifying FSH' [patent_app_type] => B1 [patent_app_number] => 09/442132 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11539 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414123.pdf [firstpage_image] =>[orig_patent_app_number] => 09442132 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/442132
Method for purifying FSH Nov 15, 1999 Issued
Array ( [id] => 1467197 [patent_doc_number] => 06458760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Method for treating tissue damaged from ischemia' [patent_app_type] => B1 [patent_app_number] => 09/439705 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11576 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458760.pdf [firstpage_image] =>[orig_patent_app_number] => 09439705 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/439705
Method for treating tissue damaged from ischemia Nov 11, 1999 Issued
Array ( [id] => 4087268 [patent_doc_number] => 06162904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Manufacturing method for intraveneously administrable immune globulin and resultant product' [patent_app_type] => 1 [patent_app_number] => 9/421405 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7142 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162904.pdf [firstpage_image] =>[orig_patent_app_number] => 421405 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/421405
Manufacturing method for intraveneously administrable immune globulin and resultant product Oct 20, 1999 Issued
Array ( [id] => 1470153 [patent_doc_number] => 06407068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells' [patent_app_type] => B1 [patent_app_number] => 09/421162 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407068.pdf [firstpage_image] =>[orig_patent_app_number] => 09421162 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/421162
Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells Oct 18, 1999 Issued
Array ( [id] => 1495403 [patent_doc_number] => 06403564 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection' [patent_app_type] => B1 [patent_app_number] => 09/417884 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15213 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403564.pdf [firstpage_image] =>[orig_patent_app_number] => 09417884 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/417884
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Oct 13, 1999 Issued
Array ( [id] => 6861190 [patent_doc_number] => 20030092198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'SITE-SPECIFIC LABELING OF DISULFIDE-CONTAINING TARGETING VECTORS' [patent_app_type] => new [patent_app_number] => 09/417109 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8579 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092198.pdf [firstpage_image] =>[orig_patent_app_number] => 09417109 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/417109
Site-specific labeling of disulfide-containing targeting vectors Oct 12, 1999 Issued
Array ( [id] => 1333465 [patent_doc_number] => 06596728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use' [patent_app_type] => B1 [patent_app_number] => 09/410083 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10626 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 753 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596728.pdf [firstpage_image] =>[orig_patent_app_number] => 09410083 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/410083
Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use Sep 30, 1999 Issued
Array ( [id] => 4411504 [patent_doc_number] => 06300470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Antibiotic cryptdin peptides and methods of their use' [patent_app_type] => 1 [patent_app_number] => 9/397386 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 18389 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300470.pdf [firstpage_image] =>[orig_patent_app_number] => 397386 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/397386
Antibiotic cryptdin peptides and methods of their use Sep 14, 1999 Issued
Array ( [id] => 4087139 [patent_doc_number] => 06162895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Peracylated insulin compositions and process for making the same' [patent_app_type] => 1 [patent_app_number] => 9/392416 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2070 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162895.pdf [firstpage_image] =>[orig_patent_app_number] => 392416 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/392416
Peracylated insulin compositions and process for making the same Sep 8, 1999 Issued
09/390275 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN AP2 INHIBITOR AND COMBINATION Sep 6, 1999 Abandoned
Array ( [id] => 1467206 [patent_doc_number] => 06458764 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'GRF analogs with increased biological potency' [patent_app_type] => B1 [patent_app_number] => 09/389486 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14612 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458764.pdf [firstpage_image] =>[orig_patent_app_number] => 09389486 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/389486
GRF analogs with increased biological potency Sep 2, 1999 Issued
Array ( [id] => 4359274 [patent_doc_number] => 06191112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Human therapeutic uses of BPI protein products' [patent_app_type] => 1 [patent_app_number] => 9/388758 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12856 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191112.pdf [firstpage_image] =>[orig_patent_app_number] => 388758 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/388758
Human therapeutic uses of BPI protein products Sep 1, 1999 Issued
09/147897 METHODS AND DEVICES FOR PREPARING PROTEIN CONCENTRATES Aug 29, 1999 Abandoned
Array ( [id] => 1068898 [patent_doc_number] => 06844424 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Method for obtaining avian biological products' [patent_app_type] => utility [patent_app_number] => 09/763724 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1301 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844424.pdf [firstpage_image] =>[orig_patent_app_number] => 09763724 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/763724
Method for obtaining avian biological products Aug 26, 1999 Issued
Array ( [id] => 7013964 [patent_doc_number] => 20010051146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE' [patent_app_type] => new [patent_app_number] => 09/180599 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4432 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051146.pdf [firstpage_image] =>[orig_patent_app_number] => 09180599 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/180599
AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE Aug 26, 1999 Abandoned
Menu